Status:
COMPLETED
Evaluation of the Remote Intervention for Diet and Exercise (RIDE)
Lead Sponsor:
Pennington Biomedical Research Center
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Overweight
Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
A large proportion of the adult population in the United States qualifies for weight loss treatment based on the NIH treatment recommendations, but traditional clinic-based weight loss treatments have...
Detailed Description
The prevalence of overweight and obesity has increased significantly over the past four decades, resulting in 66% of the adult population in the United States (U.S.) being classified as overweight or ...
Eligibility Criteria
Inclusion
- Body mass index (BMI) is \> 25 kg/m2 and \< 35 kg/m2.
- Willing to use cell phones provided by the PBRC or personal cell phones to take pictures of foods during the study and to receive messages from study personnel.
- Willing to wear an activity monitor on your shoe and to use the internet to send information as frequently as once daily.
- Willing to weigh on a scale provided by the PBRC as frequently as once per day
- Willing to accept random assignment to either the e-Health (RIDE group) or control group.
- Weight stable, defined as no greater than 4.4 lbs. (2 kg) weight change over the previous 60 days.
Exclusion
- Diagnosed with a chronic disease that affects body weight, appetite, or metabolism, namely diabetes, cardiovascular disease, cancer, and thyroid diseases or conditions.
- Currently in a weight loss program.
- Unable to engage in moderate intensity exercise.
- Unable to diet or exercise due to your medical history or current health status.
- Current use of prescriptions or over-the-counter medications or herbal products that affect appetite, body weight, or metabolism (e.g., weight loss medications such as sibutramine, antipsychotic medications such as olanzapine, ephedrine, and diuretics).
- Diagnosed with uncontrolled hypertension (high blood pressure), defined as systolic blood pressure \>159 mmHg \& diastolic blood pressure \>99 mmHg.
- For females, current pregnancy, or plans to become pregnant in the duration of the study.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00883350
Start Date
May 1 2009
End Date
January 1 2011
Last Update
December 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States, 70808